Could a Once-Every-Few-Weeks shot replace daily pills for schizophrenia?
Disease control
Not yet recruiting
This trial compares a new long-acting injectable form of the schizophrenia drug cariprazine (called B2227) with the standard oral version, Vraylar. Researchers want to see how the body absorbs and processes each version, and whether the injectable is safe and tolerable. The study…
Phase: PHASE2, PHASE3 • Sponsor: Bostal Drug Delivery Co., Ltd • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC